医薬品包装市場規模、シェア、動向、2030年までの世界予測

医薬品包装市場 – 原材料（プラスチック、紙・板紙、ガラス、金属）、種類（プラスチックボトル、ブリスター、キャップ・クロージャー、ラベル・アクセサリー、プレフィルドシリンジ）、薬剤投与、地域別 – 2030年までの世界予測

医薬品包装市場は、予測期間中に年平均成長率15.8%で成長し、2025年の1,748.5億米ドルから2030年には3,641.1億米ドルに達すると予測されています。

医薬品包装市場は、病院、薬局、オンライン薬局など、様々な分野において、安全で信頼性が高く、患者中心の包装ソリューションに対する需要の高まりを背景に、大きな成長機会を迎えています。医薬品包装は、製品の完全性を維持し、汚染を防ぎ、医薬品を便利かつ安全に配送することを可能にします。さらに、規制と安全性に関する懸念が高まるにつれ、米国食品医薬品局（FDA）と欧州医薬品庁（EMA）は、材料、シリアル番号、偽造防止に関する要件の強化を推進していくでしょう。自動車メーカーは、不正開封防止機能、チャイルドレジスタント機能、スマートパッケージなど、優れた包装システムの概念開発を強化するでしょう。安全性、規制遵守、そして子供向けの包装システムは、RFIDやQRコード対応の包装など、デジタル技術や追跡技術の導入を業界に促すでしょう。医薬品のパッケージは、将来の医療提供システムにおける医薬品の安全性、製品の信頼性、患者固有の機能への投資の継続的な進化において、移動可能かつ影響力を持つものとなるでしょう。

本調査レポートは、医薬品包装市場を、種類（プラスチックボトル、ブリスターパック、キャップおよびクロージャー、プレフィルドシリンジ、パウチおよびストリップ、プレフィルド吸入器、バイアル、アンプル、カートリッジ、ラベルおよび付属品、医療用特殊バッグ、温度管理包装、投薬チューブ、ジャーおよびキャニスター）、薬剤送達（経口薬、経肺薬、経皮薬、注射薬、局所薬、経鼻薬、眼科用薬、静脈内薬）、包装タイプ（一次包装および二次包装）、原材料（プラスチック、紙および板紙、ガラス、金属）、地域（アジア太平洋、北米、欧州、南米、中東およびアフリカ）に基づいて分類しています。レポートは、医薬品包装市場の成長に影響を与える推進要因、制約要因、課題、機会に関する詳細な情報を網羅しています。医薬品包装市場における主要プレーヤーの詳細な分析を行い、事業概要、提供製品、そして提携、協業、合併、買収、製品発売、事業拡大といった主要戦略に関する洞察を提供しています。本レポートは、医薬品包装市場エコシステムにおける新興企業の競争力分析を網羅しています。

本レポートは、市場リーダー／新規参入企業に対し、医薬品包装市場全体および各サブセグメントの収益数値に関する近似値を提供します。本レポートは、ステークホルダーが競争環境を理解し、事業のポジショニングを改善するための洞察を深め、適切な市場開拓戦略を策定するのに役立ちます。また、ステークホルダーが市場の動向を把握し、主要な市場牽引要因、制約要因、課題、そして機会に関する情報を提供するのに役立ちます。

The pharmaceutical packaging market is projected to reach USD 364.11 billion by 2030 from USD 174.85 billion in 2025, at a CAGR of 15.8% during the forecast period.

The pharmaceutical packaging market is witnessing significant growth opportunities, partly fueled by increasing demand for safe, reliable, and patient-centric packaging solutions across a variety of sectors, including hospitals, retail pharmacies, and e-pharmacies. Pharmaceutical packaging maintains the integrity of the product, stops it from becoming contaminated, and allows for convenient and safe delivery of the drug. In addition, as regulatory- and safety-motivated concerns mount, the US. The Food and Drug Administration (FDA) and the European Medicines Agency (EMA) will push for greater requirements around materials, serialization, and anti-counterfeiting. Manufacturers of vehicles will begin increasing the conceptual development of good packaging systems, like those that are tamper-evident, child-resistant, and smart packaging. Safety, regulatory compliance, and packaging systems for children will push the industry to introduce digital and track-and-trace technologies, such as packaging enabled with RFID or QR codes. Pharmaceutical packaging will be moveable and influential in the ongoing evolution of investment in drug safety, product authenticity, and patient-specific features for a system of healthcare delivery in the future.

“By packaging type, primary packaging is projected to be the fastest-growing packaging type during the forecast period.”

In the forecast period, primary packaging is projected to be the fastest-growing type of pharmaceutical packaging. This segment will grow because primary packaging is directly responsible for drug stability, sterility, and patient safety, particularly for more sensitive drugs, such as biologics and injectables. For example, the increasing demand for prefilled syringes, blister packs, vials, and ampoules indicates the manufacturing growth of pharmaceuticals and the desire for patients to have drugs packaged in more convenient formats ready for use. In addition, primary packaging is important in meeting regulatory challenges and serialization requirements. It also addresses concerns regarding tamper evidence and counterfeiting. Advances in barrier coatings, smart labels, and child-resistant closures will enhance functionality and product demand in global health care markets.

“By drug delivery, oral drugs are estimated to account for the second-largest market during the forecast period.”

Oral drug delivery is estimated to account for the largest portion of the pharmaceutical packaging market in 2024 among the delivery methods for drug delivery systems. The packaging formats related to oral drug delivery are tablets, capsules, and oral liquids, primarily because of their convenience, affordability, and ability to promote adherence, or compliance, among patients. The packaging formats for oral solid doses will include blister packs and bottles, due to their portability, ability for unit dose, and ability to protect the dose from moisture and other contaminants. Increasing trend towards self-medication, in particular in the over-the-counter self-medication market, is also driving the demand for user-friendly oral drug delivery packaging. In addition, manufacturers continue to enhance oral drug packaging with sustainable aspects and easier access for older adults (e.g., easy-to-open and clearly labeled dosage designs).

“By raw material, paper & paperboard is set to account for the second-largest market share during the forecast period.”

For the duration of the forecast period, paper & paperboard packaging is estimated to account for the second biggest market share in the pharmaceutical packaging market because this packaging type is mostly relevant to the secondary and tertiary packaging applications. The recyclable qualities of paper and paperboard materials, price advantage, and support for sustainability goals come to the forefront as pharmacy manufacturers respond to both societal and legislative pressures to limit plastic usage. The use of paperboard cartons, leaflets, and labels plays a key role in product identification, such as dose direction and legislative requirements for serialization and anti-counterfeiting, and tracking sustainability disposal practices. The sustainable focus on limited usage of plastics and overall desire to conform to the principles of a circular economy will continue to be drivers of the paper-based pharmaceutical packaging markets in developed regions, especially where sustainability initiatives are a priority.

“Asia Pacific is projected to account for the second-largest market share in the pharmaceutical packaging market during the forecast period.”

In 2024, the Asia Pacific region accounted for the second largest share within the global pharmaceutical packaging market. The sustained strength of the region is principally based upon its growing pharmaceutical manufacturing base, particularly in emerging markets such as China, India, and Japan, which are prime markets for the development of generic and branded drug products. Growth in healthcare expenditures, a growing middle-class population, and improved access to healthcare services are increasing demand for pharmaceuticals, which is also driving demand for advanced pharmaceutical packaging offerings. This trend is also supported by an increase in chronic diseases and governmental policies aimed at establishing an effective domestic supply chain for medications, both for driving the need for safe and effective pharmaceutical packaging. The growth of contract manufacturing and pharmaceutical packaging services continues to expand in the Asia Pacific region, with attendant levels of investment from established companies, allowing these players to benefit from lower-cost production capabilities and scaled efficiencies. The combination of the previously outlined trends will substantiate the Asia Pacific region as a major contributor to the accelerated growth associated with the global pharmaceutical packaging market.

• By Company Type: Tier 1: 25%, Tier 2: 42%, and Tier 3: 33%
• By Designation: C-level Executives: 20%, Directors: 30%, and Other Designations: 50%
• By Region: North America: 20%, Europe: 10%, Asia Pacific: 40%, South America: 10%, and Middle East & Africa: 20%

Notes: Other designations include sales, marketing, and product managers.

Tier 1: Greater than USD 1 Billion; Tier 2: Between USD 500 million and USD 1 Billion; and Tier 3: Less than USD 500 million

Companies Covered: Amcor PLC (Switzerland), Gerresheimer AG (Germany), Schott AG (Germany), Aptar Group, Inc. (US), BD (US), WestRock Company (US), NIPRO Corporation (Japan), Catalent Inc. (US), Sealed Air (US), and West Pharmaceutical Services (US) are covered in the report.

The study includes an in-depth competitive analysis of these key players in the pharmaceutical packaging market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the pharmaceutical packaging market based on type (plastic bottles, blister packs, caps & closures, prefilled syringes, pouches & strips, prefilled inhalers, vials, ampoules, cartridges, labels & accessories, medical specialty bags, temperature-controlled packaging, medication tubes, and jars & canisters), drug delivery (oral drugs, pulmonary, transdermal, injectables, topical, nasal, ocular/ophthalmic and iv drugs), packaging type (primary and secondary) by raw material (plastics, paper & paperboard, and glass, metal) and region (Asia Pacific, North America, Europe, South America, and Middle East & Africa). The report’s scope covers detailed information regarding the drivers, restraints, challenges, and opportunities influencing the growth of the pharmaceutical packaging market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products offered, and key strategies, such as partnerships, collaborations, mergers, acquisitions, product launches, and expansions, associated with the pharmaceutical packaging market. This report covers a competitive analysis of upcoming startups in the pharmaceutical packaging market ecosystem.

Reasons to Buy the Report

The report will offer the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall pharmaceutical packaging market and the subsegments. This report will help stakeholders understand the competitive landscape, gain more insights into positioning their businesses better, and plan suitable go-to-market strategies. The report will help stakeholders understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following points:

• Assessing the major drivers (growing healthcare expenditure and pharmaceutical industry in emerging economies, increasing demand for drug delivery devices and blister packaging, and technological advancements contributing to the growth of pharmaceutical packaging), restraints (increasing overall packaging costs owing to dynamic regulatory policies and lack of access to proper healthcare), opportunities (growing demand for primary pharmaceutical packaging and expansion of personalized medicine), and challenges (safeguarding against counterfeit products and balancing innovations with cost efficiency).
• Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and product & service launches in the pharmaceutical packaging market.
• Market Development: Comprehensive information about profitable markets – the report analyzes the pharmaceutical packaging market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the pharmaceutical packaging market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Amcor plc (Switzerland), Gerresheimer AG (Germany), Schott AG (Germany), Aptar Group, Inc. (US), BD (US), WestRock Company (US), NIPRO (Japan), Catalent Inc. (US), Sealed Air (US), and West Pharmaceutical Services (US), among others.

Table of Contents

1               INTRODUCTION              28

1.1           STUDY OBJECTIVES       28

1.2           MARKET DEFINITION   28

1.3           STUDY SCOPE   29

1.3.1        MARKETS COVERED AND REGIONAL SCOPE      29

1.3.2        INCLUSIONS AND EXCLUSIONS 30

1.3.3        YEARS CONSIDERED      31

1.3.4        UNITS CONSIDERED      31

1.3.4.1    Currency/Value unit            31

1.3.4.2    Volume unit           31

1.4           LIMITATIONS    31

1.5           STAKEHOLDERS               32

1.6           SUMMARY OF CHANGES               32

2               RESEARCH METHODOLOGY       33

2.1           RESEARCH DATA              33

2.1.1        SECONDARY DATA          34

2.1.1.1    List of key secondary sources              34

2.1.1.2    Key data from secondary sources       34

2.1.2        PRIMARY DATA 35

2.1.2.1    Key data from primary sources           35

2.1.2.2    Key industry insights           36

2.1.2.3    Breakdown of primary interviews      36

2.2           MARKET SIZE ESTIMATION         37

2.2.1        BOTTOM-UP APPROACH              37

2.2.2        TOP-DOWN APPROACH                38

2.3           DATA TRIANGULATION                38

2.4           RESEARCH ASSUMPTIONS           40

2.5           GROWTH RATE FORECAST/ASSESSMENT             40

2.5.1        SUPPLY SIDE     41

2.5.2        DEMAND SIDE  41

2.6           RISK ASSESSMENT           41

2.7           LIMITATIONS    41

3               EXECUTIVE SUMMARY  42

4               PREMIUM INSIGHTS       47

4.1           ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL PACKAGING MARKET            47

4.2           PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL           47

4.3           PHARMACEUTICAL PACKAGING MARKET, BY TYPE                 48

4.4           PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE           48

4.5           PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY            49

4.6           PHARMACEUTICAL PACKAGING MARKET, BY KEY COUNTRY            49

5               MARKET OVERVIEW       50

5.1           INTRODUCTION              50

5.2           MARKET DYNAMICS       50

5.2.1        DRIVERS               51

5.2.1.1    Growing healthcare expenditure and pharmaceutical industry in emerging economies             51

5.2.1.2    Rising demand for drug delivery devices and blister packaging                 52

5.2.1.3    Technological advancements in pharmaceutical packaging                 52

5.2.2        RESTRAINTS      53

5.2.2.1    Increase in overall packaging costs due to dynamic regulatory policies   53

5.2.2.2    Lack of access to proper healthcare in emerging economies                 53

5.2.3        OPPORTUNITIES              54

5.2.3.1    Growing demand for primary pharmaceutical packaging                 54

5.2.3.2    Growth in personalized medicine      54

5.2.4        CHALLENGES    55

5.2.4.1    Safeguarding counterfeit products    55

5.2.4.2    Balancing innovations with cost efficiency       55

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            55

5.4           ECOSYSTEM ANALYSIS  56

5.5           VALUE CHAIN ANALYSIS               58

5.6           REGULATORY LANDSCAPE         59

5.6.1        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             59

5.6.2        REGULATIONS  62

5.6.2.1    21 CFR Part 211 – Current Good Manufacturing Practice (cGMP) for Finished Pharmaceuticals (USA) 62

5.6.2.2    Federal Anti-Tampering Act (USA, 1983)       62

5.6.2.3    Fair Packaging and Labeling Act (FPLA, USA, 1967)   62

5.6.2.4    Good Manufacturing Practices (GMP – WHO Guidelines)                 62

5.6.2.5    ISO 15378:2017 – Primary Packaging Materials for Medicinal Products 62

5.6.2.6    European Pharmacopoeia (Ph. Eur.)                63

5.6.2.7    United States Pharmacopeia (USP)  63

5.6.2.8    Japanese Pharmacopoeia (JP)            63

5.6.2.9    Regulation (EU) 2017/745 on Medical Devices (MDR – Europe)                 63

5.6.2.10  International Council for Harmonisation (ICH) Guidelines                 63

5.7           TRADE ANALYSIS             63

5.7.1        IMPORT SCENARIO (HS CODE 392310)    63

5.7.2        EXPORT SCENARIO (HS CODE 392310)    64

5.8           PRICING ANALYSIS          65

5.8.1        INDICATIVE AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY RAW MATERIAL     66

5.8.2        AVERAGE SELLING PRICE TREND, BY REGION   66

5.9           TECHNOLOGY ANALYSIS             67

5.9.1        KEY TECHNOLOGIES     67

5.9.1.1    Nanotechnology    67

5.9.1.2    Packaging food biologics     67

5.9.2        COMPLEMENTARY TECHNOLOGIES       68

5.9.2.1    Smart packaging   68

5.9.3        ADJACENT TECHNOLOGIES       68

5.9.3.1    Anti-counterfeit technology                68

5.10         PATENT ANALYSIS          68

5.10.1      INTRODUCTION              68

5.10.2      LEGAL STATUS OF PATENTS      70

5.10.3      JURISDICTION ANALYSIS              70

5.11         CASE STUDY ANALYSIS 71

5.11.1      MOISTURE BARRIER TECHNOLOGY FOR BETTER DRUG DELIVERY            71

5.11.2      CUSTOM TECHNOLOGY FOR BETTER BREATHING                 71

5.11.3      STREAMLINING OPERATIONS AND REDUCING COSTS

THROUGH MD LOGISTICS           72

5.12         KEY CONFERENCES AND EVENTS             73

5.13         INVESTMENT AND FUNDING SCENARIO               74

5.14         IMPACT OF GEN AI/AI ON PHARMACEUTICAL PACKAGING MARKET    74

5.14.1      INTRODUCTION              74

5.14.2      AI-POWERED TRACKING AND BLOCKCHAIN INTEGRATION  74

5.14.3      ENHANCING PHARMACEUTICAL SECURITY THROUGH AI            75

5.14.4      SMART AND CONNECTED DRUG PACKAGING   75

5.15         PORTER’S FIVE FORCES ANALYSIS           75

5.15.1      THREAT OF NEW ENTRANTS      76

5.15.2      THREAT OF SUBSTITUTES          76

5.15.3      BARGAINING POWER OF BUYERS             76

5.15.4      BARGAINING POWER OF SUPPLIERS       77

5.15.5      INTENSITY OF COMPETITIVE RIVALRY 77

5.16         KEY STAKEHOLDERS AND BUYING CRITERIA     77

5.16.1      KEY STAKEHOLDERS IN BUYING PROCESS           77

5.16.2      BUYING CRITERIA           79

5.17         MACROECONOMIC ANALYSIS    80

5.17.1      INTRODUCTION              80

5.17.2      GDP TRENDS AND FORECASTS 80

5.18         IMPACT OF 2025 US TARIFFS ON PHARMACEUTICAL PACKAGING MARKET    81

5.18.1      INTRODUCTION              81

5.18.2      KEY TARIFF RATES          81

5.18.3      IMPACT ON COUNTRY/REGION                81

5.18.3.1  US           81

5.18.3.2  Europe   81

5.18.3.3  Asia Pacific            81

5.18.4      IMPACT ON TYPES          82

5.18.4.1  Plastic bottles        82

5.18.4.2  Medication tubes  82

5.18.4.3  Other types            82

6               PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE           83

6.1           INTRODUCTION              84

6.2           PRIMARY              85

6.2.1        INNOVATIVE PACKAGING SOLUTIONS FOR DRUG DELIVERY

SYSTEMS TO DRIVE MARKET      85

6.3           SECONDARY      85

6.3.1        RISE IN ADOPTION OF PREFILLED CONTAINERS AND DELIVERY

DEVICES TO FUEL DEMAND       85

7               PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL           86

7.1           INTRODUCTION              87

7.2           PLASTIC               89

7.2.1        EXCELLENT BARRIER PROPERTIES AND COST-EFFECTIVENESS

TO DRIVE MARKET         89

7.2.2        HIGH-DENSITY POLYETHYLENE               90

7.2.3        POLYESTER        90

7.2.4        POLYPROPYLENE            90

7.2.5        LOW-DENSITY POLYETHYLENE                90

7.2.6        POLYVINYL CHLORIDE 91

7.2.7        CYCLIC OLEFIN COPOLYMER     91

7.2.8        POLYETHYLENE TEREPHTHALATE         91

7.3           PAPER & PAPERBOARD 91

7.3.1        INNOVATIONS IN SECONDARY PACKAGING TO PROPEL MARKET               91

7.4           GLASS   93

7.4.1        CHEMICAL RESISTANCE AND EFFECTIVE PROTECTION TO BOOST MARKET        93

7.5           METAL 95

7.5.1        INCREASE IN USE OF ALUMINUM FOR BLISTER PACKAGING

TO DRIVE MARKET         95

7.6           OTHER RAW MATERIALS              96

8               PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY            98

8.1           INTRODUCTION              99

8.2           ORAL     101

8.2.1        ADOPTION OF NANOCARRIERS AND CYCLODEXTRINS TO FUEL MARKET            101

8.3           INJECTABLE       102

8.3.1        RISE IN USE OF BIOLOGICS TO BOOST MARKET                 102

8.4           TOPICAL              103

8.4.1        RISE IN PREVALENCE OF SKIN DISEASES TO BOOST DEMAND FOR TOPICAL DRUGS                103

8.5           OCULAR/OPHTHALMIC                104

8.5.1        INCREASE IN PREVALENCE OF OPHTHALMIC DISEASES TO DRIVE MARKET         104

8.6           NASAL  105

8.6.1        RAPID ABSORPTION AND QUICK ACTION TO FUEL DEMAND FOR NASAL DROPS     105

8.7           PULMONARY     106

8.7.1        RISE IN CASES OF LUNG DISORDERS TO DRIVE MARKET                 106

8.8           TRANSDERMAL 107

8.8.1        RISE IN DEMAND FOR PAINLESS DRUG DELIVERY AND SELF-ADMINISTRATION OF DRUGS TO FUEL MARKET  107

8.9           INTRAVENOUS 108

8.9.1        HIGH OCCURRENCE OF CHRONIC DISEASES TO DRIVE DEMAND             108

8.10         OTHER DRUG DELIVERY MODES              109

9               PHARMACEUTICAL PACKAGING MARKET, BY TYPE                 111

9.1           INTRODUCTION              112

9.2           PLASTIC BOTTLES           114

9.2.1        EXTENSIVE USE IN PACKAGING ORAL DRUGS TO DRIVE DEMAND             114

9.2.2        STANDARD PLASTIC BOTTLES  115

9.2.3        PLASTIC DISPENSING BOTTLES                115

9.2.4        PLASTIC JARS    116

9.3           BLISTER PACKS 116

9.3.1        ANTIMICROBIAL RESISTANCE AND TAMPER-EVIDENT FEATURES TO DRIVE MARKET   116

9.3.2        COMPARTMENT PACKS                117

9.3.3        WALLET PACKS 117

9.4           LABELS & ACCESSORIES                117

9.4.1        STRINGENT GUIDELINES REGARDING DRUG INSTRUCTIONS TO DRIVE MARKET        117

9.4.2        SELF-ADHESIVE                118

9.4.3        DIE-CUT               118

9.4.4        HOLOGRAPHIC STRIPS 119

9.4.5        TAMPER-PROOF               119

9.4.6        OTHER LABELS & ACCESSORIES                119

9.5           CAPS & CLOSURES           119

9.5.1        DEMAND FOR CHILD-RESISTANT AND TAMPER-EVIDENT PACKAGING

TO FUEL MARKET            119

9.6           MEDICAL SPECIALTY BAGS         120

9.6.1        INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE DEMAND               120

9.7           PREFILLED SYRINGES    121

9.7.1        RISE IN NEED FOR HIGH-QUALITY DRUG DELIVERY SYSTEMS

TO BOOST MARKET        121

9.8           TEMPERATURE-CONTROLLED PACKAGING       122

9.8.1        RISE IN DEMAND FOR TEMPERATURE-SENSITIVE DRUGS AND

VACCINES TO FUEL MARKET     122

9.9           POUCHES & STRIP PACKS             123

9.9.1        RISE IN DEMAND FOR COST-EFFECTIVE SOLUTIONS TO DRIVE MARKET 123

9.10         AMPOULES         124

9.10.1      GROWTH IN DEMAND FOR SMALL DOSAGE SOLUTIONS TO DRIVE MARKET         124

9.11         VIALS    125

9.11.1      DEMAND FOR VIALS IN VACCINE PACKAGING TO DRIVE GROWTH             125

9.12         PREFILLED INHALERS   126

9.12.1      HIGH DEMAND FOR CONVENIENT AND ECO-FRIENDLY PACKAGING TO DRIVE MARKET               126

9.12.2      METERED DOSE INHALERS         127

9.12.3      DRY POWDER INHALERS              127

9.13         MEDICATION TUBES     128

9.13.1      INCREASE IN DEMAND IN CURING SKIN AILMENTS TO DRIVE MARKET 128

9.13.2      COMPOSITE TUBES        129

9.13.3      ALL-PLASTIC TUBES      129

9.13.4      COLLAPSIBLE METAL TUBES     129

9.14         JARS & CANISTERS           129

9.14.1      EFFECTIVE BARRIER PROPERTIES TO FUEL DEMAND FOR DESICCANT CANISTERS      129

9.15         CARTRIDGES     130

9.15.1      INCREASED USE IN CHRONIC DISEASES TO DRIVE MARKET               130

9.16         OTHER TYPES   131

10            PHARMACEUTICAL PACKAGING MARKET, BY REGION                 133

10.1         INTRODUCTION              134

10.2         NORTH AMERICA             135

10.2.1      US           140

10.2.1.1  Rapid technological advancements in pharmaceutical packaging to fuel growth        140

10.2.2      CANADA               142

10.2.2.1  Expansion of pharmaceutical industry and increase in consumption of pharmaceutical products to boost market             142

10.2.3      MEXICO                144

10.2.3.1  Increase in chronic diseases and presence of free-trade agreements to fuel demand for pharmaceutical products               144

10.3         EUROPE               146

10.3.1      GERMANY           152

10.3.1.1  Investment in innovations in biologics and sustainable materials, aligning with EU regulations on packaging waste reduction to drive market                 152

10.3.2      FRANCE                154

10.3.2.1  High demand for generic drugs and investment in biotherapies to drive market          154

10.3.3      ITALY    156

10.3.3.1  Rise in exports of pharmaceuticals to boost market        156

10.3.4      UK          158

10.3.4.1  Innovations in drug manufacturing with reliable legal system and strong protection of intellectual property to drive market             158

10.3.5      SPAIN    160

10.3.5.1  High-quality, cost-effective manufacturing capabilities, well-established R&D facilities in healthcare sector to boost demand 160

10.3.6      RUSSIA 162

10.3.6.1  Government initiatives for domestic production of pharmaceuticals to fuel market           162

10.3.7      REST OF EUROPE             164

10.4         ASIA PACIFIC     166

10.4.1      CHINA  172

10.4.1.1  Increased investments in R&D of biologics and biosimilar drugs to drive market      172

10.4.2      JAPAN   174

10.4.2.1  Global leader in product innovation with sizeable aging population to drive demand for medications   174

10.4.3      SOUTH KOREA  176

10.4.3.1  Well-developed healthcare industry and presence of major pharmaceutical manufacturers to drive market                176

10.4.4      INDIA    178

10.4.4.1  Large domestic consumption and export of generic drugs to drive market    178

10.4.5      AUSTRALIA         180

10.4.5.1  Wide adoption of Medicare and PBS schemes to drive market                 180

10.4.6      REST OF ASIA PACIFIC   182

10.5         SOUTH AMERICA             184

10.5.1      BRAZIL 189

10.5.1.1  Large availability of required raw materials, cost-effective labor, and robust regulatory policies to boost market                189

10.5.2      ARGENTINA       191

10.5.2.1  Prevalence of noncommunicable diseases to boost market despite sharp economic deceleration, remediated by government stabilization measures                191

10.5.3      REST OF SOUTH AMERICA           193

10.6         MIDDLE EAST & AFRICA                195

10.6.1      SAUDI ARABIA  201

10.6.1.1  More comprehensive access to healthcare services to fuel demand for pharmaceuticals              201

10.6.2      UAE        203

10.6.2.1  Increasing initiatives for domestic pharmaceutical production to drive market          203

10.6.3      SOUTH AFRICA 205

10.6.3.1  Gradual rise in generic drug use to drive market             205

10.6.4      REST OF MIDDLE EAST & AFRICA             206

11            COMPETITIVE LANDSCAPE         209

11.1         OVERVIEW          209

11.2         KEY PLAYER STRATEGIES             209

11.3         MARKET SHARE ANALYSIS           211

11.4         REVENUE ANALYSIS       214

11.5         COMPANY VALUATION AND FINANCIAL METRICS                 215

11.5.1      COMPANY VALUATION 216

11.5.2      FINANCIAL METRICS      216

11.6         PRODUCT/BRAND COMPARISON             217

11.7         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 219

11.7.1      STARS   219

11.7.2      EMERGING LEADERS     219

11.7.3      PERVASIVE PLAYERS      219

11.7.4      PARTICIPANTS 219

11.7.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         221

11.7.5.1  Company footprint               221

11.7.5.2  Regional Footprint                221

11.7.5.3  Raw material footprint         222

11.7.5.4  Type footprint       223

11.7.5.5  Drug delivery footprint        224

11.7.5.6  Packaging type footprint     225

11.8         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        225

11.8.1      PROGRESSIVE COMPANIES         225

11.8.2      RESPONSIVE COMPANIES            225

11.8.3      DYNAMIC COMPANIES  226

11.8.4      STARTING BLOCKS         226

11.8.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 227

11.8.5.1  Detailed list of key startups/SMEs    227

11.8.5.2  Competitive benchmarking of key startups/SMEs          228

11.9         COMPETITIVE SCENARIO             229

11.9.1      PRODUCT LAUNCHES   229

11.9.2      DEALS  232

11.9.3      EXPANSIONS     236

12            COMPANY PROFILES      241

12.1         KEY PLAYERS     241

12.1.1      AMCOR PLC (INCLUDING BERRY GLOBAL)          241

12.1.1.1  Business overview 241

12.1.1.2  Products/Solutions/Services offered 242

12.1.1.3  Recent developments           244

12.1.1.3.1                Product launches  244

12.1.1.3.2                Deals      245

12.1.1.3.3                Expansions             245

12.1.1.4  MnM view              246

12.1.1.4.1                Right to win           246

12.1.1.4.2                Strategic choices   246

12.1.1.4.3                Weaknesses and competitive threats 247

12.1.2      GERRESHEIMER AG         248

12.1.2.1  Business overview 248

12.1.2.2  Products/Solutions/Services offered 249

12.1.2.3  Recent developments           251

12.1.2.3.1                Product launches  251

12.1.2.3.2                Deals      252

12.1.2.3.3                Expansions             253

12.1.2.4  MnM view              254

12.1.2.4.1                Right to win           254

12.1.2.4.2                Strategic choices   254

12.1.2.4.3                Weaknesses and competitive threats 254

12.1.3      SCHOTT AG        255

12.1.3.1  Business overview 255

12.1.3.2  Products/Solutions/Services offered 256

12.1.3.3  Recent developments           257

12.1.3.3.1                Product launches  257

12.1.3.3.2                Deals      258

12.1.3.3.3                Expansions             258

12.1.3.4  MnM view              259

12.1.3.4.1                Right to win           259

12.1.3.4.2                Strategic choices   259

12.1.3.4.3                Weaknesses and competitive threats 260

12.1.4      APTARGROUP, INC.        261

12.1.4.1  Business overview 261

12.1.4.2  Products/Solutions/Services offered 262

12.1.4.3  Recent developments           263

12.1.4.3.1                Product launches  263

12.1.4.3.2                Deals      264

12.1.4.4  MnM view              265

12.1.4.4.1                Right to win           265

12.1.4.4.2                Strategic choices   265

12.1.4.4.3                Weaknesses and competitive threats 265

12.1.5      BD          266

12.1.5.1  Business overview 266

12.1.5.2  Products/Solutions/Services offered 268

12.1.5.3  Recent developments           268

12.1.5.3.1                Product launches  268

12.1.5.3.2                Deals      269

12.1.5.3.3                Expansions             270

12.1.5.4  MnM view              270

12.1.5.4.1                Right to win           270

12.1.5.4.2                Strategic choices   270

12.1.5.4.3                Weaknesses & competitive threats     271

12.1.6      WESTROCK COMPANY  272

12.1.6.1  Business overview 272

12.1.6.2  Products/Solutions/Services offered 273

12.1.6.3  Recent developments           273

12.1.6.3.1                Deals      273

12.1.6.4  MnM view              273

12.1.7      NIPRO   274

12.1.7.1  Business overview 274

12.1.7.2  Products/Solutions/Services offered 275

12.1.7.3  Recent developments           276

12.1.7.3.1                Product launches  276

12.1.7.4  MnM view              276

12.1.8      CATALENT, INC                277

12.1.8.1  Business overview 277

12.1.8.2  Products/Solutions/Services offered 278

12.1.8.3  Recent developments           279

12.1.8.3.1                Deals      279

12.1.8.3.2                Expansions             280

12.1.8.4  MnM view              281

12.1.9      SEALED AIR        282

12.1.9.1  Business overview 282

12.1.9.2  Products/Solutions/Services offered 283

12.1.9.3  Recent developments           284

12.1.9.3.1                Product launches  284

12.1.9.3.2                Deals      284

12.1.9.4  MnM view              285

12.1.10   WEST PHARMACEUTICAL SERVICES, INC.             286

12.1.10.1                 Business overview 286

12.1.10.2                 Products/Solutions/Services offered 287

12.1.10.3                 Recent developments           288

12.1.10.3.1             Product launches  288

12.1.10.3.2             Deals      289

12.1.10.3.3             Expansions             289

12.1.10.4                 MnM view              290

12.2         OTHER PLAYERS              291

12.2.1      ALPLA   291

12.2.2      ARDAGH GROUP S.A.     292

12.2.3      CCL INDUSTRIES INC.    293

12.2.4      FRANK NOE        294

12.2.5      GAPLAST GMBH               295

12.2.6      LONZA 296

12.2.7      MONDI 297

12.2.8      NOLATO AB       298

12.2.9      ORIGIN PHARMA PACKAGING   299

12.2.10   COMAR 300

12.2.11   BILCARE LIMITED           301

12.2.12   SGD PHARMA    302

12.2.13   SILGAN PLASTICS            303

12.2.14   VETTER PHARMA INTERNATIONAL GMBH          304

12.2.15   SVAM TOYAL PACKAGING INDUSTRIES PVT. LTD.                 305

13            APPENDIX           306

13.1         DISCUSSION GUIDE        306

13.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                310

13.3         CUSTOMIZATION OPTIONS        312

13.4         RELATED REPORTS         312

13.5         AUTHOR DETAILS           313

LIST OF TABLES

TABLE 1                INCLUSIONS AND EXCLUSIONS 30

TABLE 2                SUMMARY OF CHANGES               32

TABLE 1                LIST OF KEY SECONDARY SOURCES        34

TABLE 2                RISK ASSESSMENT           41

TABLE 3                ROLES OF COMPANIES IN PHARMACEUTICAL PACKAGING ECOSYSTEM             57

TABLE 4                NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS  60

TABLE 5                EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS                 60

TABLE 6                ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS             61

TABLE 7                MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS  61

TABLE 8                SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS  62

TABLE 9                IMPORT SCENARIO FOR HS CODE 392310-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION)            64

TABLE 10              EXPORT SCENARIO FOR HS CODE 392310-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION)            65

TABLE 11              INDICATIVE PRICING ANALYSIS OF PHARMACEUTICAL PACKAGING OFFERED BY KEY PLAYERS, BY RAW MATERIAL, 2023-2030 (USD/KG)     66

TABLE 12              INDICATIVE AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING, BY REGION, 2023–2030 (USD/KG)            67

TABLE 13              PHARMACEUTICAL PACKAGING MARKET: KEY CONFERENCES AND EVENTS,

2025–2026              73

TABLE 14              IMPACT OF PORTER’S FIVE FORCES ON PHARMACEUTICAL PACKAGING MARKET            76

TABLE 15              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE TYPES                78

TABLE 16              KEY BUYING CRITERIA FOR KEY TYPES 79

TABLE 17              GLOBAL GDP GROWTH PROJECTION, BY REGION, 2021–2028 (USD TRILLION)        80

TABLE 18              PHARMACEUTICAL PACKAGING MARKET, PACKAGING TYPE,

2022–2024 (USD MILLION)            84

TABLE 19              PHARMACEUTICAL PACKAGING MARKET, PACKAGING TYPE,

2025–2030 (USD MILLION)            84

TABLE 20              PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL,

2022–2024 (USD MILLION)            87

TABLE 21              PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL,

2025–2030 (USD MILLION)            88

TABLE 22              PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL,

2022–2024 (KILOTON)     88

TABLE 23              PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL,

2025–2030 (KILOTON)     88

TABLE 24              PHARMACEUTICAL PLASTIC PACKAGING MARKET, BY REGION,

2022–2024 (USD MILLION)            89

TABLE 25              PHARMACEUTICAL PLASTIC PACKAGING MARKET, BY REGION,

2025–2030 (USD MILLION)            89

TABLE 26              PHARMACEUTICAL PAPER & PAPERBOARD PACKAGING MARKET, BY REGION, 2022–2024 (USD MILLION)                 92

TABLE 27              PHARMACEUTICAL PAPER & PAPERBOARD PACKAGING MARKET,

BY REGION, 2025–2030 (USD MILLION)   92

TABLE 28              PHARMACEUTICAL GLASS PACKAGING MARKET, BY REGION,

2022–2024 (USD MILLION)            93

TABLE 29              PHARMACEUTICAL GLASS PACKAGING MARKET, BY REGION,

2025–2030 (USD MILLION)            93

TABLE 30              TYPES OF GLASS USED FOR DIFFERENT PACKAGING       94

TABLE 31              PHARMACEUTICAL METAL PACKAGING MARKET, BY REGION,

2022–2024 (USD MILLION)            95

TABLE 32              PHARMACEUTICAL METAL PACKAGING MARKET, BY REGION,

2025–2030 (USD MILLION)            96

TABLE 33              OTHER PHARMACEUTICAL PACKAGING RAW MATERIALS MARKET, BY REGION, 2022–2024 (USD MILLION)                 96

TABLE 34              OTHER PHARMACEUTICAL PACKAGING RAW MATERIALS MARKET, BY REGION, 2025–2030 (USD MILLION)                 97

TABLE 35              PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY,

2022–2024 (USD MILLION)            100

TABLE 36              PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY,

2025–2030 (USD MILLION)            100

TABLE 37              PHARMACEUTICAL PACKAGING MARKET FOR ORAL DRUGS, BY REGION,

2022–2024 (USD MILLION)            101

TABLE 38              PHARMACEUTICAL PACKAGING MARKET FOR ORAL DRUGS, BY REGION,

2025–2030 (USD MILLION)            101

TABLE 39              PHARMACEUTICAL PACKAGING MARKET FOR INJECTABLE DRUGS, BY REGION, 2022–2024 (USD MILLION)                 102

TABLE 40              PHARMACEUTICAL PACKAGING MARKET FOR INJECTABLE DRUGS, BY REGION, 2025–2030 (USD MILLION)                 102

TABLE 41              PHARMACEUTICAL PACKAGING MARKET FOR TOPICAL DRUGS, BY REGION,

2022–2024 (USD MILLION)            103

TABLE 42              PHARMACEUTICAL PACKAGING MARKET FOR TOPICAL DRUGS, BY REGION,

2025–2030 (USD MILLION)            103

TABLE 43              PHARMACEUTICAL PACKAGING MARKET FOR OCULAR/OPHTHALMIC DRUGS,

BY REGION, 2022–2024 (USD MILLION)   104

TABLE 44              PHARMACEUTICAL PACKAGING MARKET FOR OCULAR/OPHTHALMIC DRUGS,

BY REGION, 2025–2030 (USD MILLION)   105

TABLE 45              PHARMACEUTICAL PACKAGING MARKET FOR NASAL DRUGS, BY REGION,

2022–2024 (USD MILLION)            105

TABLE 46              PHARMACEUTICAL PACKAGING MARKET FOR NASAL DRUGS, BY REGION,

2025–2030 (USD MILLION)            106

TABLE 47              PHARMACEUTICAL PACKAGING MARKET FOR PULMONARY DRUGS, BY REGION, 2022–2024 (USD MILLION)                 107

TABLE 48              PHARMACEUTICAL PACKAGING MARKET FOR PULMONARY DRUGS, BY REGION, 2025–2030 (USD MILLION)                 107

TABLE 49              PHARMACEUTICAL PACKAGING MARKET FOR TRANSDERMAL DRUGS, BY REGION, 2022–2024 (USD MILLION)                 108

TABLE 50              PHARMACEUTICAL PACKAGING MARKET FOR TRANSDERMAL DRUGS, BY REGION, 2025–2030 (USD MILLION)                 108

TABLE 51              PHARMACEUTICAL PACKAGING MARKET FOR INTRAVENOUS DRUGS, BY REGION, 2022–2024 (USD MILLION)                 109

TABLE 52              PHARMACEUTICAL PACKAGING MARKET FOR INTRAVENOUS DRUGS, BY REGION, 2025–2030 (USD MILLION)                 109

TABLE 53              PHARMACEUTICAL PACKAGING MARKET FOR OTHER DRUG DELIVERY MODES,

BY REGION, 2022–2024 (USD MILLION)   110

TABLE 54              PHARMACEUTICAL PACKAGING MARKET FOR OTHER DRUG DELIVERY MODES,

BY REGION, 2025–2030 (USD MILLION)   110

TABLE 55              PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION)                113

TABLE 56              PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION)                114

TABLE 57             PHARMACEUTICAL PLASTIC BOTTLES MARKET, BY REGION,

2022–2024 (USD MILLION)            115

TABLE 58             PHARMACEUTICAL PLASTIC BOTTLES MARKET, BY REGION,

2025–2030 (USD MILLION)            115

TABLE 59              PHARMACEUTICAL BLISTER PACKS MARKET, BY REGION,

2022–2024 (USD MILLION)            116

TABLE 60              PHARMACEUTICAL BLISTER PACKS MARKET, BY REGION,

2025–2030 (USD MILLION)            117

TABLE 61              PHARMACEUTICAL LABELS & ACCESSORIES MARKET, BY REGION,

2022–2024 (USD MILLION)            118

TABLE 62              PHARMACEUTICAL LABELS & ACCESSORIES MARKET, BY REGION,

2025–2030 (USD MILLION)            118

TABLE 63              PHARMACEUTICAL CAPS & CLOSURES MARKET, BY REGION,

2022–2024 (USD MILLION)            120

TABLE 64              PHARMACEUTICAL CAPS & CLOSURES MARKET, BY REGION,

2025–2030 (USD MILLION)            120

TABLE 65              MEDICAL SPECIALTY BAGS MARKET, BY REGION, 2022–2024 (USD MILLION)          121

TABLE 66              MEDICAL SPECIALTY BAGS MARKET, BY REGION, 2025–2030 (USD MILLION)          121

TABLE 67              PHARMACEUTICAL PREFILLED SYRINGES MARKET, BY REGION,

2022–2024 (USD MILLION)            122

TABLE 68              PHARMACEUTICAL PREFILLED SYRINGES MARKET, BY REGION,

2025–2030 (USD MILLION)            122

TABLE 69              PHARMACEUTICAL TEMPERATURE-CONTROLLED PACKAGING MARKET,

BY REGION, 2022–2024 (USD MILLION)   123

TABLE 70              PHARMACEUTICAL TEMPERATURE-CONTROLLED PACKAGING MARKET,

BY REGION, 2025–2030 (USD MILLION)   123

TABLE 71              PHARMACEUTICAL POUCHES & STRIP PACKS MARKET, BY REGION,

2022–2024 (USD MILLION)            124

TABLE 72              PHARMACEUTICAL POUCHES & STRIP PACKS MARKET, BY REGION,

2025–2030 (USD MILLION)            124

TABLE 73              PHARMACEUTICAL AMPOULES MARKET, BY REGION, 2022–2024 (USD MILLION)          125

TABLE 74              PHARMACEUTICAL AMPOULES MARKET, BY REGION, 2025–2030 (USD MILLION)          125

TABLE 75              PHARMACEUTICAL VIALS MARKET, BY REGION, 2022–2024 (USD MILLION)            126

TABLE 76              PHARMACEUTICAL VIALS MARKET, BY REGION, 2025–2030 (USD MILLION)            126

TABLE 77              PHARMACEUTICAL PREFILLED INHALERS MARKET, BY REGION,

2022–2024 (USD MILLION)            127

TABLE 78              PHARMACEUTICAL PREFILLED INHALERS MARKET, BY REGION,

2025–2030 (USD MILLION)            127

TABLE 79              PHARMACEUTICAL MEDICATION TUBES MARKET, BY REGION,

2022–2024 (USD MILLION)            128

TABLE 80              PHARMACEUTICAL MEDICATION TUBES MARKET, BY REGION,

2025–2030 (USD MILLION)            128

TABLE 81              PHARMACEUTICAL JARS & CANISTERS MARKET, BY REGION,

2022–2024 (USD MILLION)            129

TABLE 82              PHARMACEUTICAL JARS & CANISTERS MARKET, BY REGION,

2025–2030 (USD MILLION)            130

TABLE 83              PHARMACEUTICAL CARTRIDGES MARKET, BY REGION, 2022–2024 (USD MILLION)          130

TABLE 84              PHARMACEUTICAL CARTRIDGES MARKET, BY REGION, 2025–2030 (USD MILLION)          131

TABLE 85              OTHER PHARMACEUTICAL PACKAGING TYPES MARKET, BY REGION,

2022–2024 (USD MILLION)            131

TABLE 86              OTHER PHARMACEUTICAL PACKAGING TYPES MARKET, BY REGION,

2025–2030 (USD MILLION)            132

TABLE 87              PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022–2024 (USD MILLION)          134

TABLE 88              PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2025–2030 (USD MILLION)          134

TABLE 89              NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY,

2022–2024 (USD MILLION)            136

TABLE 90              NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY,

2025–2030 (USD MILLION)            136

TABLE 91              NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2022–2024 (USD MILLION)            136

TABLE 92              NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2025–2030 (USD MILLION)            137

TABLE 93              NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2022–2024 (USD MILLION)            137

TABLE 94              NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2025–2030 (USD MILLION)            137

TABLE 95              NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2022–2024 (USD MILLION)            138

TABLE 96              NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2025–2030 (USD MILLION)            138

TABLE 97              NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022–2024 (USD MILLION)            139

TABLE 98              NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025–2030 (USD MILLION)            139

TABLE 99              NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022–2024 (KT)                 139

TABLE 100            NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025–2030 (KT)                 140

TABLE 101            US: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION)         141

TABLE 102            US: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION)         142

TABLE 103            CANADA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2022–2024 (USD MILLION)            143

TABLE 104            CANADA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2025–2030 (USD MILLION)            144

TABLE 105            MEXICO: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2022–2024 (USD MILLION)            145

TABLE 106            MEXICO: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2025–2030 (USD MILLION)            146

TABLE 107            EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY,

2022–2024 (USD MILLION)            147

TABLE 108            EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY,

2025–2030 (USD MILLION)            147

TABLE 109            EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2022–2024 (USD MILLION)            148

TABLE 110            EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2025–2030 (USD MILLION)            149

TABLE 111            EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE,

2022–2024 (USD MILLION)            149

TABLE 112            EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE,

2025–2030 (USD MILLION)            149

TABLE 113            EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY,

2022–2024 (USD MILLION)            150

TABLE 114            EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE, 2025–2030 (USD MILLION)                 150

TABLE 115            EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL,

2022–2024 (USD MILLION)            151

TABLE 116            EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL,

2025–2030 (USD MILLION)            151

TABLE 117            EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL,

2022–2024 (KT)   151

TABLE 118            EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL,

2025–2030 (KT)   152

TABLE 119            GERMANY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2022–2024 (USD MILLION)            153

TABLE 120            GERMANY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2025–2030 (USD MILLION)            154

TABLE 121            FRANCE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2022–2024 (USD MILLION)            155

TABLE 122            FRANCE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2025–2030 (USD MILLION)            156

TABLE 123            ITALY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2022–2024 (USD MILLION)            157

TABLE 124            ITALY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2025–2030 (USD MILLION)            158

TABLE 125            UK: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION)         159

TABLE 126            UK: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION)         160

TABLE 127            SPAIN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2022–2024 (USD MILLION)            161

TABLE 128            SPAIN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2025–2030 (USD MILLION)            162

TABLE 129            RUSSIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2022–2024 (USD MILLION)            163

TABLE 130            RUSSIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2025–2030 (USD MILLION)            164

TABLE 131            REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2022–2024 (USD MILLION)            165

TABLE 132            REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2025–2030 (USD MILLION)            166

TABLE 133            ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY,

2022–2024 (USD MILLION)            167

TABLE 134            ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY,

2025–2030 (USD MILLION)            168

TABLE 135            ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2022–2024 (USD MILLION)            168

TABLE 136            ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2025–2030 (USD MILLION)            169

TABLE 137            ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2022–2024 (USD MILLION)                 169

TABLE 138            ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2025–2030 (USD MILLION)                 169

TABLE 139            ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY,

2022–2024 (USD MILLION)            170

TABLE 140            ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY, 2025–2030 (USD MILLION)                 170

TABLE 141            ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL,

2022–2024 (USD MILLION)            171

TABLE 142            ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL,

2025–2030 (USD MILLION)            171

TABLE 143            ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL,

2022–2024 (KT)   171

TABLE 144            ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL,

2025–2030 (KT)   172

TABLE 145            CHINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2022–2024 (USD MILLION)            173

TABLE 146            CHINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2025–2030 (USD MILLION)            174

TABLE 147            JAPAN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2022–2024 (USD MILLION)            175

TABLE 148            JAPAN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2025–2030 (USD MILLION)            176

TABLE 149            SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2022–2024 (USD MILLION)            177

TABLE 150            SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2025–2030 (USD MILLION)            178

TABLE 151            INDIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2022–2024 (USD MILLION)            179

TABLE 152            INDIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2025–2030 (USD MILLION)            180

TABLE 153            AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2022–2024 (USD MILLION)            181

TABLE 154            AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2025–2030 (USD MILLION)            182

TABLE 155            REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2022–2024 (USD MILLION)            183

TABLE 156            REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2025–2030 (USD MILLION)            184

TABLE 157            SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY,

2022–2024 (USD MILLION)            185

TABLE 158            SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY,

2025–2030 (USD MILLION)            185

TABLE 159            SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2022–2024 (USD MILLION)            185

TABLE 160            SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2025–2030 (USD MILLION)            186

TABLE 161            SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2022–2024 (USD MILLION)            186

TABLE 162            SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2025–2030 (USD MILLION)            186

TABLE 163            SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2022–2024 (USD MILLION)            187

TABLE 164            SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2025–2030 (USD MILLION)            187

TABLE 165            SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022–2024 (USD MILLION)            188

TABLE 166            SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025–2030 (USD MILLION)            188

TABLE 167            SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022–2024 (KT)                 188

TABLE 168            SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025–2030 (KT)                 189

TABLE 169            BRAZIL: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2022–2024 (USD MILLION)            190

TABLE 170            BRAZIL: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2025–2030 (USD MILLION)            191

TABLE 171            ARGENTINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2022–2024 (USD MILLION)            192

TABLE 172            ARGENTINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2025–2030 (USD MILLION)            193

TABLE 173            REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2022–2024 (USD MILLION)                 194

TABLE 174            REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2025–2030 (USD MILLION)                 195

TABLE 175            MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2022–2024 (USD MILLION)                 196

TABLE 176            MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2025–2030 (USD MILLION)                 196

TABLE 177            MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2022–2024 (USD MILLION)            197

TABLE 178            MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2025–2030 (USD MILLION)            198

TABLE 179            MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2022–2024 (USD MILLION)            198

TABLE 180            MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2025–2030 (USD MILLION)            198

TABLE 181            MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2022–2024 (USD MILLION)            199

TABLE 182            MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2025–2030 (USD MILLION)            199

TABLE 183            MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022–2024 (USD MILLION)            200

TABLE 184            MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025–2030 (USD MILLION)            200

TABLE 185            MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2022–2024 (KT)                 200

TABLE 186            MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2025–2030 (KT)                 201

TABLE 187            SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2022–2024 (USD MILLION)            202

TABLE 188            SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2025–2030 (USD MILLION)            203

TABLE 189            UAE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2022–2024 (USD MILLION)            204

TABLE 190            UAE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2025–2030 (USD MILLION)            204

TABLE 191            SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2022–2024 (USD MILLION)            205

TABLE 192            SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE,

2025–2030 (USD MILLION)            206

TABLE 193            REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET,

BY TYPE, 2022–2024 (USD MILLION)         207

TABLE 194            REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET,

BY TYPE, 2025–2030 (USD MILLION)         208

TABLE 195            PHARMACEUTICAL PACKAGING MARKET: OVERVIEW OF MAJOR STRATEGIES ADOPTED BY KEY PLAYERS, JANUARY 2020–AUGUST 2025       210

TABLE 196            PHARMACEUTICAL PACKAGING MARKET: DEGREE OF COMPETITION, 2024               212

TABLE 197            PHARMACEUTICAL PACKAGING MARKET: REGIONAL FOOTPRINT, 2024      221

TABLE 198            PHARMACEUTICAL PACKAGING MARKET: RAW MATERIAL FOOTPRINT, 2024      222

TABLE 199            PHARMACEUTICAL PACKAGING MARKET: TYPE FOOTPRINT, 2024             223

TABLE 200            PHARMACEUTICAL PACKAGING MARKET: DRUG DELIVERY FOOTPRINT, 2024          224

TABLE 201            PHARMACEUTICAL PACKAGING MARKET: PACKAGING TYPE FOOTPRINT, 2024       225

TABLE 202            PHARMACEUTICAL PACKAGING MARKET: DETAILED LIST OF

KEY STARTUPS/SMES, 2024          227

TABLE 203            PHARMACEUTICAL PACKAGING MARKET: COMPETITIVE BENCHMARKING

OF KEY STARTUPS/SMES, 2024   228

TABLE 204            PHARMACEUTICAL PACKAGING MARKET: PRODUCT LAUNCHES,

JANUARY 2020-AUGUST 2025       229

TABLE 205            PHARMACEUTICAL PACKAGING MARKET: DEALS, JANUARY 2020–AUGUST 2025       232

TABLE 206            PHARMACEUTICAL PACKAGING MARKET: EXPANSIONS,

JANUARY 2020–AUGUST 2025       237

TABLE 207            AMCOR PLC: COMPANY OVERVIEW        241

TABLE 208            AMCOR PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED    242

TABLE 209            PHARMACEUTICAL PACKAGING MARKET: PRODUCT LAUNCHES   244

TABLE 210            PHARMACEUTICAL PACKAGING MARKET: DEALS  245

TABLE 211            PHARMACEUTICAL PACKAGING MARKET: EXPANSIONS     245

TABLE 212            GERRESHEIMER AG: COMPANY OVERVIEW                 248

TABLE 213            GERRESHEIMER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED    249

TABLE 214            GERRESHEIMER AG: PRODUCT LAUNCHES                 251

TABLE 215            GERRESHEIMER AG: DEALS         252

TABLE 216            GERRESHEIMER AG: EXPANSIONS            253

TABLE 217            SCHOTT AG: COMPANY OVERVIEW        255

TABLE 218            SCHOTT AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED    256

TABLE 219            SCHOTT AG: PRODUCT LAUNCHES        257

TABLE 220            SCHOTT AG: DEALS        258

TABLE 221            SCHOTT AG: EXPANSIONS           258

TABLE 222            APTAR GROUP, INC.: COMPANY OVERVIEW                 261

TABLE 223            APTARGROUP, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    262

TABLE 224            APTAR GROUP, INC.: PRODUCT LAUNCHES                 263

TABLE 225            APTAR GROUP, INC.: DEALS       264

TABLE 226            BD: COMPANY OVERVIEW           266

TABLE 227            BD: PRODUCTS/SOLUTIONS/SERVICES OFFERED             268

TABLE 228            BD: PRODUCT LAUNCHES           268

TABLE 229            BD: DEALS          269

TABLE 230            BD: EXPANSIONS             270

TABLE 231            WESTROCK COMPANY: COMPANY OVERVIEW                 272

TABLE 232            WESTROCK COMPANY: PRODUCTS/SOLUTIONS/SERVICES OFFERED    273

TABLE 233            WESTROCK COMPANY: DEALS  273

TABLE 234            NIPRO: COMPANY OVERVIEW   274

TABLE 235            NIPRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED             275

TABLE 236            NIPRO: PRODUCT LAUNCHES   276

TABLE 237            CATALENT, INC.: COMPANY OVERVIEW                 277

TABLE 238            CATALENT, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    278

TABLE 239            CATALENT, INC.: DEALS               279

TABLE 240            CATALENT, INC.: EXPANSIONS 280

TABLE 241            SEALED AIR: COMPANY OVERVIEW         282

TABLE 242            SEALED AIR: PRODUCTS/SOLUTIONS/SERVICES OFFERED             283

TABLE 243            SEALED AIR: PRODUCT LAUNCHES         284

TABLE 244            SEALED AIR: DEALS        284

TABLE 245            WEST PHARMACEUTICAL SERVICES: COMPANY OVERVIEW          286

TABLE 246            WEST PHARMACEUTICAL SERVICES: PRODUCTS/SOLUTIONS/SERVICES OFFERED    287

TABLE 247            WEST PHARMACEUTICAL SERVICES: PRODUCT LAUNCHES          288

TABLE 248            WEST PHARMACEUTICAL SERVICES: DEALS                 289

TABLE 249            WEST PHARMACEUTICAL SERVICES: EXPANSIONS     289

TABLE 250            ALPLA: COMPANY OVERVIEW   291

TABLE 251            ARDAGH GROUP S.A.: COMPANY OVERVIEW                 292

TABLE 252            CCL INDUSTRIES INC.: COMPANY OVERVIEW                 293

TABLE 253            FRANK NOE: COMPANY OVERVIEW         294

TABLE 254            GAPLAST GMBH: COMPANY OVERVIEW                 295

TABLE 255            LONZA: COMPANY OVERVIEW  296

TABLE 256            MONDI: COMPANY OVERVIEW 297

TABLE 257            NOLATO AB: COMPANY OVERVIEW        298

TABLE 258            ORIGIN PHARMA PACKAGING: COMPANY OVERVIEW          299

TABLE 259            COMAR: COMPANY OVERVIEW 300

TABLE 260            BILCARE LIMITED: COMPANY OVERVIEW                 301

TABLE 261            SGD PHARMA: COMPANY OVERVIEW     302

TABLE 262            SILGAN PLASTICS: COMPANY OVERVIEW                 303

TABLE 263            VETTER PHARMA INTERNATIONAL GMBH: COMPANY OVERVIEW   304

TABLE 264            SVAM TOYAL PACKAGING INDUSTRIES PVT. LTD.: COMPANY OVERVIEW       305

LIST OF FIGURES

FIGURE 1              PHARMACEUTICAL PACKAGING MARKET SEGMENTATION AND REGIONAL SCOPE              29

FIGURE 2              STUDY YEARS CONSIDERED       31

FIGURE 3              PHARMACEUTICAL PACKAGING MARKET: RESEARCH DESIGN         33

FIGURE 1              KEY DATA FROM SECONDARY SOURCES                 34

FIGURE 2              KEY DATA FROM PRIMARY SOURCES     35

FIGURE 3              KEY INDUSTRY INSIGHTS             36

FIGURE 1              BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE,

DESIGNATION, AND REGION     36

FIGURE 2              PHARMACEUTICAL PACKAGING MARKET: BOTTOM-UP APPROACH              37

FIGURE 3              PHARMACEUTICAL PACKAGING MARKET: TOP-DOWN APPROACH          38

FIGURE 4              PHARMACEUTICAL PACKAGING MARKET: DATA TRIANGULATION                39

FIGURE 5              RESEARCH ASSUMPTIONS           40

FIGURE 6              LIMITATIONS    41

FIGURE 7              PLASTIC BOTTLES SEGMENT TO LEAD AMONG PACKAGE TYPES

IN 2025 AND 2030              43

FIGURE 8              PRIMARY PACKAGING TO ACCOUNT FOR LARGER SHARE

DURING FORECAST PERIOD       44

FIGURE 9              PLASTIC SEGMENT TO ACCOUNT FOR LARGEST MARKET

SHARE DURING FORECAST PERIOD        44

FIGURE 10            INJECTABLES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD       45

FIGURE 11            ASIA PACIFIC TO BE FASTEST-GROWING PHARMACEUTICAL PACKAGING MARKET            46

FIGURE 12            ASIA PACIFIC TO OFFER LUCRATIVE OPPORTUNITIES IN PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD       47

FIGURE 13            PLASTICS SEGMENT TO RECORD FASTEST GROWTH DURING FORECAST PERIOD  47

FIGURE 14            PLASTIC BOTTLES SEGMENT TO BE LARGEST MARKET               48

FIGURE 15            PRIMARY PHARMACEUTICAL PACKAGING SEGMENT TO RECORD LARGEST MARKET AND FASTEST GROWTH DURING FORECAST PERIOD  48

FIGURE 16            INJECTABLES SEGMENT TO RECORD FASTEST GROWTH

DURING FORECAST PERIOD       49

FIGURE 17            INDIA TO DOMINATE MARKET DURING FORECAST PERIOD         49

FIGURE 18            DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PHARMACEUTICAL PACKAGING MARKET                 51

FIGURE 19            TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS IN PHARMACEUTICAL PACKAGING MARKET               56

FIGURE 20            PHARMACEUTICAL PACKAGING MARKET: ECOSYSTEM       57

FIGURE 21            PHARMACEUTICAL PACKAGING MARKET: VALUE CHAIN ANALYSIS               58

FIGURE 22            IMPORT DATA FOR HS CODE 392310-COMPLIANT PRODUCTS,

BY KEY COUNTRY, 2020–2024 (USD MILLION)     64

FIGURE 24            PATENTS APPLIED AND GRANTED, 2014–2024                 69

FIGURE 25            LEGAL STATUS OF PATENTS, 2014–2024 70

FIGURE 26            TOP JURISDICTIONS      70

FIGURE 27            PHARMACEUTICAL PACKAGING MARKET: INVESTOR DEALS AND FUNDING TRENDS, 2020–2024 (USD MILLION)            74

FIGURE 28            PORTER’S FIVE FORCES ANALYSIS OF PHARMACEUTICAL PACKAGING MARKET            75

FIGURE 29            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE TYPES                78

FIGURE 31            PRIMARY PACKAGING SEGMENT TO DOMINATE OVERALL PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD       84

FIGURE 32            PHARMACEUTICAL PLASTIC PACKAGING TO DOMINATE PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD         87

FIGURE 33            INJECTABLES SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2024                99

FIGURE 34            PLASTIC BOTTLES TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD        112

FIGURE 35            NORTH AMERICA: MARKET SNAPSHOT 135

FIGURE 36            ASIA PACIFIC: MARKET SNAPSHOT          167

FIGURE 37            PHARMACEUTICAL PACKAGING MARKET SHARE ANALYSIS, 2024   212

FIGURE 38            PHARMACEUTICAL PACKAGING MARKET: REVENUE ANALYSIS OF

KEY COMPANIES, 2020–2024 (USD BILLION)         215

FIGURE 39            PHARMACEUTICAL PACKAGING MARKET: COMPANY VALUATION,

2024 (USD BILLION)        216

FIGURE 40            PHARMACEUTICAL PACKAGING MARKET: FINANCIAL MATRIX:

EV/EBITDA RATIO, 2024                 216

FIGURE 41            PHARMACEUTICAL PACKAGING MARKET: YEAR-TO-DATE PRICE AND

FIVE-YEAR STOCK BETA, 2024     217

FIGURE 42            PHARMACEUTICAL PACKAGING MARKET: PRODUCT/BRAND COMPARISON             218

FIGURE 43            PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024  220

FIGURE 44            PHARMACEUTICAL PACKAGING MARKET: COMPANY FOOTPRINT, 2024      221

FIGURE 45            PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024                 226

FIGURE 46            AMCOR PLC: COMPANY SNAPSHOT        242

FIGURE 47            GERRESHEIMER AG: COMPANY SNAPSHOT                 249

FIGURE 48            SCHOTT AG: COMPANY SNAPSHOT        256

FIGURE 49            APTARGROUP, INC.: COMPANY SNAPSHOT                 262

FIGURE 50            BD: COMPANY SNAPSHOT           267

FIGURE 51            WESTROCK COMPANY: COMPANY SNAPSHOT                 272

FIGURE 52            NIPRO: COMPANY SNAPSHOT   275

FIGURE 53            CATALENT, INC.: COMPANY SNAPSHOT                 277

FIGURE 54            SEALED AIR: COMPANY SNAPSHOT         283

FIGURE 55            WEST PHARMACEUTICAL SERVICES: COMPANY SNAPSHOT          287

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• データセンターUPS市場規模、シェア、動向、2030年までの世界予測 2025-10-31
• 高純度ガス市場規模、シェア、動向、2030年までの世界予測 2025-10-30
• 動物用生物学的製剤市場規模、シェア、動向、2030年までの世界予測 2025-10-30
• エンジニアリング樹脂向け難燃剤市場規模、シェア、動向、2030年までの世界予測 2025-10-29
• アプリケーションモダナイゼーションサービス市場規模、シェア、動向、2031年までの世界予測 2025-10-29

MarketsandMarkets  出版レポート一覧